Jill Diane Leversage

This profile gathers the share dealings of Jill Diane Leversage in Aurinia Pharmaceuticals Inc. We count 15 filings; the first trade dates from 13 November 2019 and the latest from 21 May 2024.

Every open-market trade on record is a purchase: 7 purchases worth €64k, and no sale. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. The rest of the record consists of 2 option exercises.

In size, the median ticket on the buying side is €5,440. The 6 purchases reviewed show no overlap with other insiders buying the same stock within a month.

On 23 May 2024 came the latest disclosure, an option exercise in Aurinia Pharmaceuticals Inc. The last insider purchase was made public on 16 December 2021, 1,789 days ago. Typically, a trade is published a median of 3 days after it takes place. Section 16 rules allow two business days to file each Form 4. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.